1. University of Texas MD Anderson Cancer Center, Houston, TX;
2. Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China;
3. Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ), Heidelberg, Germany;
4. National Cancer Centre Singapore, Singapore, Singapore;
5. Knight Cancer Institute, OHSU, Portland, OR;
6. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA;
7. Institut Curie and University of Paris, Paris, France;
8. St Vincent’s University Hospital and Cancer Trials Ireland, Dublin, Ireland;
9. Seattle Children’s Hospital and University of Washington School of Medicine, Seattle, WA;
10. Vanderbilt University Medical Center, Nashville, TN;
11. Klinikum Stuttgart-Olgahospital, Stuttgart, Germany;
12. Department of Oncology, Rigshospitalet, Copenhagen, Denmark;
13. National Cancer Center Hospital East, Kashiwa, Japan;
14. Chrestos Concept GmbH & Co. KG, Essen, Germany;
15. Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ;
16. Bayer HealthCare Pharmaceuticals, Inc., Basel, Switzerland;
17. Bayer AG, Wuppertal, Germany;
18. Sun Yat-sen University Cancer Center, Guangzhou, China;
19. The Children’s Hospital of Philadelphia/University of Pennsylvania, Philadelphia, PA;
20. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;